secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2022-12-06T23:59:59+00:00
Accession:  0001100682-22-000037
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Labs appoints Dr. Craig B. Thompson to Board
----------------------------------------------------------

- Board expanded from 10 to 11; Dr. Thompson appointed effective Dec. 5, 2022.
- Appointed to Science & Technology Committee and Strategic Planning & Capital Allocation Committee.
- Initial pro-rata equity award valued at $255,500 (50% RSUs, 50% stock options).
- Thompson is former CEO of Memorial Sloan Kettering (2010-2022) and current Regeneron board member.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000110068222000037/0001100682-22-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000110068222000037/crl-20221205.htm
  HTML page:      https://secwatch.observer/filing/0001100682-22-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer